In This Section

Program

Please note that this meeting will take place as an in-person event in San Diego and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise.  Program in progress.

*-Short talk from highly rated abstract

Saturday, February 1

SUNDAY, FEBRUARY 2

MONDAY, FEBRUARY 3

TUESDAY, FEBRUARY 4

Saturday, February 1

Registration

4-8 p.m.

Welcome and Keynote Lectures

6:30-8:10 p.m.

  • Welcome and Opening Remarks
    Margaret A. Goodell, Baylor College of Medicine, Houston, Texas
  • Introduction of Keynote Speaker
    Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • The role of DNMT3A in myeloid malignancies
    Timothy J. Ley, Washington University School of Medicine, St. Louis, Missouri
  • Introduction of Keynote Speaker
    Peter A. Jones, Van Andel Institute, Grand Rapids, Michigan
  • Origins of DNA methylation alterations in cancer
    Peter W. Laird, Van Andel Institute, Grand Rapids, Michigan

OPENING RECEPTION

8:10-10 p.m.

SUNDAY, FEBRUARY 2

CONTINENTAL BREAKFAST

7-8 a.m.

PLENARY SESSION 1: Twenty-Five Years Later: New Concepts in Cancer Epigenetics

8-9:50 a.m.

  • Susan J. Clark, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
  • Jean-Pierre J. Issa, Coriell Institute for Medical Research, Camden, New Jersey
  • Hariharan Easwaran, Johns Hopkins University School of Medicine, Baltimore, Maryland

BREAK

9:50-10:10 a.m.

PLENARY SESSION 2: Interpreting Methylation Signals

10:10 a.m.-12:20 p.m.

  • Dirk Schuebeler, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
  • Victor Corces, Emory University School of Medicine, Atlanta, Georgia
  • Manel Esteller, Josep Carreras Leukemia Research Institute, Barcelona, Spain

LUNCH ON OWN / Free Time
12:20-4 P.M.

12:20-4 p.m.

Plenary Session 3: DNA Methylation in a Chromatin Context

4-6 p.m.

  • Xiaodong Cheng, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Peter A. Jones, Van Andel Institute, Grand Rapids, Michigan
  • Margaret A. Goodell, Baylor College of Medicine, Houston, Texas

Lightning Talk A

6-6:15 p.m.

Poster A and Reception

6:15-8:45 p.m.

MONDAY, FEBRUARY 3

CONTINENTAL BREAKFAST

7-8 a.m.

Plenary Session 4: Role of DNA Methylation and Hydroxymethylation in Immune Cell Function

8-9:50 a.m.

  • Yun Nancy Huang, Texas A&M University, Houston, Texas
  • Benjamin A. Youngblood, St. Jude Children’s Research Hospital, Memphis, Tennessee
  • Anjana Rao, La Jolla Institute for Immunology and University of California at San Diego, La Jolla, California

BREAK

9:50-10:10 a.m.

Plenary Session 5: Clonal Hematopoiesis

10:10 a.m.-12:30 p.m.

Session Chair: Kirsten Grønbaek, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  • Kirsten Grønbaek
  • Jennifer Trowbridge, The Jackson Laboratory, Bar Harbor, Maine
  • Alexander G. Bick, Vanderbilt University Medical Center, Nashville, Tennessee
  • Katherine King, Baylor College of Medicine, Houston, Texas

LUNCH ON OWN / Free Time

12:20-4 p.m.

Plenary Session 6: Normal and Abnormal Methylation Patterns and Detection

4:30-6:20 p.m.

Session Chair: Ting Wang, Washington University in St. Louis, St. Louis, Missouri

  • Ting Wang
  • Tommy Kaplan, The Hebrew University of Jerusalem, Jerusalem, Israel
  • Daniel D. De Carvalho, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada

Lightning Talk b

6:20-6:45 p.m.

Poster b and Reception

6:45-9:15 p.m.

TUESDAY, FEBRUARY 4

CONTINENTAL BREAKFAST

7-8 a.m.

Rising Star Keynote

8-8:45 a.m.

  • Introduction of Rising Star Keynote Speaker
    Margaret A. Goodell, Baylor College of Medicine, Houston, Texas
  • Keynote Speaker
    Zuzana Tothova, Dana-Farber Cancer Institute, Boston, Massachusetts

BREAK

8:45-9 a.m.

Plenary Session 7: New DNMTis, Combinations, and Responses

9-10:45 a.m.

  • Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Guillermo Garcia-Manero, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Maria (Ken) Figueroa, University of Miami, Miami, Florida

Closing Remarks and Departure

10:45 a.m.